CU NR 546 PSYCHOPHARMACOLOGY COMPREHENSIVE EXAM 2025 | 86 VERIFIED Q&A WITH STEP-BY-STEP CLINICAL EXPLANATIONS | COMPLETE COVERAGE OF ANTIDEPRESSANTS, ANTIPSYCHOTICS, MOOD STABILIZERS & ANXIOLYTICS

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall with Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/85

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No study sessions yet.

86 Terms

1
New cards

How does reviewing the genetic makeup of a client help guide the PMHNP in selecting medication for clients?

Genetic testing can assist by providing more information on how clients may respond to certain psychotropic medications, as well as providing information on how a client may break down and metabolize medications based on the cytochrome P450 system.

There may be an environmental exposure that turned a gene "on" that should have been "off" for one twin to develop schizophrenia and not the other

. Both environmental and psychosocial stressors can impact mental health. Although twins may have identical genes, their gene expression may be different.

2
New cards

Neuroscience

is the study of the structure and function of the brain and is a field which is making great advancements (Pliszka, 2016). A strong foundational understanding of neuroscience and how the structure and function of the brain can result in mental health symptoms is necessary to treat mental illnesses.

Some mental disorders such as Alzheimer's disease, schizophrenia, and major depressive disorder are thought to be a result of malformations or malfunctions within the brain.

The psychiatric mental health nurse practitioner (PMHNP) must comprehend how medications impact the brain in order to safely and effectively prescribe psychotropic medications.

3
New cards

Brain tissue

is composed of gray and white matter.

4
New cards

gray matter

The cerebellum, cerebrum, brain stem, and the butterfly-shaped portion of the central spinal cord are comprised of gray matter which contains neural cell bodies, axon terminals, dendrites, and all nerve synapses.

It is the working area of the brain and the focus of psychiatry and neurology.

5
New cards

Gray matter

associated with learning.

Changes in the gray matter are linked to psychiatric diagnoses including Alzheimer's disease, schizophrenia, and major depressive disorder.

6
New cards

White Matter

contains nerve fibers that connect neurons from different regions into functional circuits.

The myelin that coats neuronal axons is necessary for electrical impulse transmission.

Think of the white matter as a transit system. If there are breaks in the system, then people cannot get to their destinations.

Within the brain, these breaks affect neural communication, affecting behavior.

Damage to the myelin can impair transmission which can impact not only sensory and motor function, but also cognition.

White matter abnormalities are associated with autism and vascular dementia.

7
New cards

The central sulcus separates which lobes?

frontal lobe from parietal lobe

8
New cards

Frontal lobe

Associated with movement, intelligence, abstract thinking. etc.

9
New cards

Broca's area

Speech

10
New cards

Temporal lobe

Involves object identification and auditory signals

11
New cards

Cerebellum

coordination and balance

12
New cards

Wernicke's area

Speech comprehension

13
New cards

occipital lobe

Primary visual area

14
New cards

parietal lobe

Keeps us alert to what is going on around us

15
New cards

Sensory Cortex

Pain, heat, and other sensations

16
New cards

motor cortex

Movement

17
New cards

Hippocampus

Involved in both memory and anxiety

18
New cards

Nucleus accumbens

Involved in the reward process.

19
New cards

Thalamus

Involved in sensory organ and motor command processing

20
New cards

Striatum

Involved in complex motor actions, also links cognition to motor actions

21
New cards

Limbic System

This includes circuits that are associated with pleasure and reward, emotion and learning

22
New cards

Basal ganglia

A group of structures involved in voluntary motor movements

23
New cards

Amygdala

Involved in emotional regulation and perception of odors

24
New cards

Corpus callosum

Controls the communication between the two brain hemispheres

25
New cards

white matter

Contains nerve fibers that connect neurons from different regions into functional circuits

26
New cards

Grey matter

Contains nerve cells and dendrites

27
New cards

Brain tissue

Made up of grey matter and white matter

28
New cards

What is the global burden of disease of mental health, neurological, and substance use disorders?

30%

29
New cards

How many children and adolescents are impacted by mental health disorders worldwide?

20%

30
New cards

How much does lost productivity related to anxiety and depression cost the global economy each

$1 trillion USD

31
New cards

The development of mental health conditions are linked to causes

such as genetics, biochemical processes, environment, and lifestyle. Mental illness is common, and treatment often includes the use of psychotropic medications.

32
New cards

When prescribing medications, the psychiatric mental health nurse practitioner (PMHNP) must consider each client's unique circumstances including, but not limited to their:

symptoms

age

physical health

previous response to treatment

lifestyle

33
New cards

Treatment for mental health conditions requires

individualized care that incorporates the client's desires and goals.

34
New cards

Which is the priority data used to determine a treatment plan for mental health disorders?

client symptoms

35
New cards

Adherence

can be defined as persistence or compliance.

Persistence is taking the medication over the intended time period.

Compliance is taking the medication as prescribed. According to Dell'Osso et al. (2020), client, clinician, and structural factors all contribute to non-adherence.

36
New cards

Client factors that contribute to nonadherence include

concern about

side effects,

fear of addiction to medications,

misunderstanding of expected outcomes.

37
New cards

Clinician factors that contribute to nonadherence include

lack of shared-decision making with the client, providing inadequate education about medications, and lack of follow up.

38
New cards

Structural factors that contribute to nonadherence include

medication access, medication cost, and stigma associated with mental illness.

39
New cards

Informed Consent

Clients have the right to receive enough information to make decisions about treatment.

They must also be informed about potential risks associated with medications.

Clients have the right to refuse treatment and cannot be forcibly medicated in non-emergencies.

However, clients can be forcibly medicated if they are violent toward themselves or others and when less restrictive methods have failed.

40
New cards

Compliance

A court order may be issued for a client to receive treatment against their wishes if they are considered a danger to themselves or others.

Examples include clients with schizophrenia or sex offenders. Guardians can also provide consent for clients who have limited cognitive capabilities or are incompetent to make decisions.

Ultimately, PMHNPs are responsible for being knowledgeable about their state laws and abiding by them.

41
New cards

Off-Label Perscribing

Some clients may benefit from the unapproved use of a drug for symptom management. For example, many selective serotonin reuptake inhibitors (SSRIs) are used to treat anxiety and obsessive-compulsive disorder but are not FDA approved for use in this disorder.

Off-label prescribing potentially raises ethical and legal concerns; the PMHNP must remain up to date with the latest recommendations for off-label prescribing.

42
New cards

What should the PMHNP consider when prescribing chemical restraints for this client?

Prescribing considerations include carefully reviewing the client's allergy status and prior medication history for adverse drug reactions related to the medications ordered in the chemical restraint.

If the client has a known allergy and was given the medication, the prescriber and staff could be held liable for harm to the client. Also, state regulations regarding chemical restraints must be reviewed, as some states do not allow court-ordered treatment against a client's wishes.

43
New cards

Are the PMHNP and other staff liable if the client has an allergic reaction or adverse side effects to the drugs used for chemical restraint?

No. The client has been court-ordered to take the prescribed medications and the standing order for chemical restraints is approved. The PMHNP and other staff are not liable if the patient has an allergic reaction or adverse side effects.

44
New cards

Normal and abnormal genes both contribute to

disease and drug efficacy.

45
New cards

Epigenetics

can contribute to the risk of any disorder or disease. Psychiatric disorders can also be due to normal genes that are "on" that should be "off."

46
New cards

Mental health diagnoses contribute significantly

to the global burden of disease.

47
New cards

to appropriately prescribe psychotropic medications.

A strong understanding of the functions of the brain and neurotransmitter roles in illness and treatment is needed

48
New cards

Psychiatric prescribing decisions are based

on neuroscience and symptom presentation.

49
New cards

The field of epigenetics

is rapidly growing and can help explain how gene expression is influenced by environmental factors and how epigenetics contributes to the manifestation of mental illness.

50
New cards

when prescribing medications including

Consideration must also be given to each client's unique their symptoms, age, physical health, and lifestyle.

51
New cards

The potential legal and ethical issues impacting mental health treatment must

also be taken into account, including informed consent, competence to make healthcare decisions, and off-label prescribing.

52
New cards

Which of the following is a prominent CYP enzyme in the body and what is it responsible for?

CYP3A4 - responsible for metabolism of a number of medications

Dosing adjustments may be required.

53
New cards

What is the direct role of transcription factor?

influence gene expression

54
New cards

antagonist effect

antagonist effect - drug binds to receptor, but does not activate a response

55
New cards

Partial agonist

drug does not fully activate receptors

56
New cards

Inverse agonist -

drug causes opposite effect of the agonist.

57
New cards

Which is a first messenger?

neurotransmitter- G protein linked systems and ion channel linked cascades are triggered by neurotransmitters.

58
New cards

Which action explains an agonists effect on ligand-gated ion channels?

Agonists cause ligand-gated ion channels to open more frequently.

59
New cards

When prescribing psychotropic medications, the PMHNP knows that these medications work within which specific areas?

mood

60
New cards

dorsolateral prefrontal cortex (DLPFC)

is concerned with higher level functioning

61
New cards

VLPFC (ventrolateral prefrontal cortex)

involved with motor inhibition the IFG contains Broca's area which is associated with speech production understanding grammar.

62
New cards

Basal ganglia

are a group of structures involved in voluntary motor movements. Basal ganglia are also involved in cognition and emotion.

63
New cards

Psychosis

can be an overwhelming experience for clients, making them feel out of control and out of touch with reality.

64
New cards

Antipsychotic medications

can be effective in reducing the symptoms of psychosis.

65
New cards

Psychosis is a syndrome

that can be associated with several different psychiatric disorders.

66
New cards

Symptoms of psychosis include

hallucinations, delusions, disorganized speech, disorganized behavior, and distortions of reality.

This syndrome can affect a person's cognition, affective response, communication, capacity to recognize reality, and ability to relate to others

67
New cards

Psychosis

is a defining feature for some psychotic disorders while other disorders may have a psychotic component.

68
New cards

Psychosis is a defining

feature for some psychotic disorders while other disorders may have a psychotic component.

69
New cards

Diagnoses Requiring the Presence of Psychosis

schizophrenia

substance-induced psychotic disorders

schizophreniform disorder

schizoaffecive disorder

delusional disorder

brief psychotic disorder

psychotic disorder due to a medical condition

70
New cards

Diagnoses with Psychosis as a Feature

mania

depression

cognitive disorders

dementia

71
New cards

Schizophrenia

is one of the most common disorders treated by antipsychotic medications. The prevalence of schizophrenia is difficult to determine due to the complexity of the diagnosis and other factors.

Current estimates place the prevalence of schizophrenia and related psychotic disorders in the U.S. between 0.25% and 0.64% with international estimates of the prevalence of schizophrenia among non-institutionalized persons is 0.33% to 0.75%

72
New cards

Positive symptoms

H allucinations

D elusions

T hought disorder

H ostility

E xcitability

73
New cards

Motor symptoms

Motor delay

Dyscoordination

EPS, e.g.,ParkinsonismDyskinesia

74
New cards

Active symptoms

Depression

Anxiety

Suicidality

75
New cards

Cognition

Attention

Working memory

Verbal memory

Visual memory

Executive functioning

Processing speed

Social conditioning

76
New cards

Negative symptoms

Affective flattening

Alogia

Anhedonia

Amotivation

Asociality

77
New cards

Genetics

Many genes play a role in the likelihood that an individual will develop schizophrenia as do epigenetic factors. Heritability for schizophrenia may be as high as 79% .

Evidence exists that links gene-environment interaction to the diagnosis of schizophrenia

78
New cards

Environmental Triggers

Regular Cannabis Use

Exposure to Early Life

Trauma Sexual

Abuse Emotional

Abuse Emotional

Neglect

Bullying

79
New cards

Neuroanatomy

Several areas of the brain are associated with the symptoms of schizophrenia.

When brain circuitry in the prefrontal cortex malfunctions, patients may experience symptoms.

80
New cards

Mesocortical and ventromedial prefrontal cortex

negative and affective symptoms

81
New cards

Dorsolateral:

cognitive symptoms

82
New cards

Orbitofrontal and connections to the amygdala:

aggressive, impulsive symptoms

83
New cards

Dopamine Role in Psychosis

Many theories exist regarding the causes of psychosis and schizophrenia. A leading hypothesis is that psychosis and schizophrenia are associated with a dysfunction of the neurotransmitter dopamine (DA) (Stahl, 2021).

Dopamine dysfunctions are also involved in other conditions that cause psychosis, such as severe depression, certain medical disorders, and substance abuse.

Traditionally, schizophrenia and psychosis symptoms have been associated with a surplus of dopamine, since medications that block dopamine, specifically D2, have been found to reduce the positive symptoms of schizophrenia. Stahl (2021) suggests that it is more likely that schizophrenia symptoms are related to "out of tune" dopamine

84
New cards

Medications to treat psychosis are classified as either

first generation antipsychotics (FGAs) or second- generation antipsychotics (SGAs).

Antipsychotics are prescribed based on their pharmacological properties, side effect profiles, and adverse effects according to the unique symptoms and needs of individuals across the lifespan.

Within medication management, medications from this and other classes are used across many diagnoses, making the former naming conventions inaccurate.

Selecting medications based on mechanism of action allows for precise, individualized prescribing as specific symptoms are targeted. ​

85
New cards

First generation antipsychotics (FGAs) are also known as

typical antipsychotics and are appropriate for acute and chronic management of schizophrenia and psychosis.

86
New cards

First Generation Antipsychotics

Desirable Effects

Improves Positive Symptoms

Acute & Chronic Schizophrenia & Psychosis

Non-selectively blocks dopamine D2 receptors, specifically in mesolimbic pathway

Undesirable Effects

Risk of Developing

Hyperprolactinemia Desirable Effects

Improves Positive Symptoms

Acute & Chronic Schizophrenia & Psychosis

Non-selectively blocks dopamine D2 receptors, specifically in mesolimbic pathway

Undesirable Effects

Risk of Developing

Hyperprolactinemia

& Extrapyramidal Symptoms

(Negative Symptoms

Unaffected)